HMG CoA reductase Ab in serum
Jump to navigation
Jump to search
Indications
- evaluation of immune-mediated necrotizing myopathy
Clinical significance
- generally associated with statin exposure[2]
- may be found without immune-mediated necrotizing myopathy
More general terms
More specific terms
Additional terms
References
- ↑ Loinc
- ↑ 2.0 2.1 Medical Knowledge Self Assessment Program (MKSAP) 18, American College of Physicians, Philadelphia 2018
- ↑ Musset L, Allenbach Y, Benveniste O et al Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Autoimmun Rev. 2016 Oct;15(10):983-93. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27491568